twitter

Tuesday, 19 May 2015

Re: Systematic Review Finds Long-term Coffee, Tea, and Caffeine Consumption May Reduce the Risk of Cognitive Disorders Associated with Aging

Re: Systematic Review Finds Long-term Coffee, Tea, and Caffeine Consumption May Reduce the Risk of Cognitive Disorders Associated with Aging
Panza F, Solfrizzi V, Barulli MR, et al. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J Nutr Health Aging. March 2015;19(3):313-328.
As life expectancy has increased, the incidence of aging-related disorders has also increased globally. These disorders include cognitive decline, such as mild cognitive impairment (MCI), dementia, and Alzheimer's disease (AD). AD is associated with intraneuronal and extraneuronal protein aggregates, some of which form plaques on neurons. Treatment of AD has focused on decreasing aggregate load, but more recently the focus has shifted to prevention of aggregate formation in the decades before onset of the disease. Some evidence suggests increasing intake of fruits, vegetables, fish, and monounsaturated and n-3 polyunsaturated fatty acids can reduce the risk of AD and other types of dementia and cognitive decline. Other evidence suggests that caffeine intake can reduce the risks of neurologic disorders. Animal studies have found that caffeine can reduce oxidative stress and the neuronal plaques associated with AD. The goal of this systematic review was to investigate the relationship of coffee (Coffea spp., Rubiaceae), tea (Camellia sinensis, Theaceae), and caffeine consumption with cognitive ability in older subjects.
The databases PubMed, Ovid MEDLINE, EMBASE, Google Scholar, Web of Science, and Scopus were searched for the terms coffee, tea, or caffeine in combination with the terms cognitive impairment, decline or deterioration, dementia, Alzheimer's disease, or mild cognitive impairment. The databases were searched for studies published in any language before January 2014. Human, cross-sectional and longitudinal, population-based studies and case-controlled studies were included. Of the 631 studies found from the search, 28 met all of the criteria and were included in the review.
Most of the cross-sectional studies (n = 10) reviewed found an increase in measures of cognitive ability with caffeine intake. In one study with subjects under the age of 50, cognitive function increased with coffee consumption. In all but one of the remaining cross-sectional studies, some or all of the measures of cognitive ability were positively correlated with caffeine intake. In five of the studies, coffee, tea, or caffeine intake resulted in increased cognitive function. In one study conducted within a Chinese population, tea consumption increased cognitive function in men but not women. In another study, caffeine intake increased cognitive function in only one of 12 cognitive tests.
In three of the longitudinal population-based studies (n = 12), caffeine intake showed no effect on cognitive ability. In seven of the longitudinal studies, coffee, tea, or caffeine intake was associated with a decrease in cognitive decline. One study found that patients with MCI were less likely to progress to dementia as plasma levels of caffeine increased. A review of longitudinal studies cited found a consistent increase in cognitive ability with tea consumption. While an effect on cognitive ability was also found with coffee consumption, it was less consistent than that found with tea.
The results of the cross-sectional studies that specifically addressed dementia, AD, and MCI had mixed results. One showed no protective effect of caffeine on these neurological disorders, while another found a positive effect of caffeine on AD, and another found a positive effect in men in the highest quartile of caffeine consumption. Of the seven longitudinal studies that measured the effect of coffee, tea, and caffeine consumption on neurologic disorders, three found no associations, while three found a positive effect of coffee but not tea. One meta-analysis found that coffee consumption lowered the risk of developing AD.
In general, cognitive ability and a reduction in risk of cognitive disorders associated with aging appear to be associated with long-term coffee, tea, and caffeine intake. There appears to be a stronger correlation between cognitive ability and tea consumption than coffee and a stronger correlation between reduction in cognitive disorders and coffee consumption than tea. There also appeared to be a stronger effect found in women than men. Some of the studies cited in this review found no correlation between long-term coffee, tea, or caffeine intake and cognitive ability or cognitive disorders. There is evidence that both caffeine and other compounds found within tea and coffee reduce oxidative stress. But, it is still unclear if the positive effects seen on cognitive decline are a result of caffeine alone or in combination with these other compounds.
There are several limitations found in the studies cited in this review. The most important is the lack of correlation among the studies themselves. Additionally, factors, such as diet and lifestyle, may be correlated with coffee, tea, and caffeine consumption and may influence cognitive function and decline. Other compounds found in coffee and tea may also affect cognitive function and slow cognitive decline. Lastly, total amounts of caffeine can vary greatly with the serving size, source, and processing of coffee or tea so that caffeine intake can be vastly different from one cup of coffee or tea to the next. Further studies should control for factors including actual caffeine intake, gender, lifestyle, diet, alcohol consumption, and smoking. Additionally, the authors state that future studies would benefit from the inclusion of neuroimaging to measure plaque formation associated with neurodegenerative diseases.
­–Cheryl McCutchan, PhD